- CompletedPhase II
A study of pazopanib efficacy and safety in patients with advanced clear-cell renal cell carcinoma and ECOG Performance Status 2 (PaZ02)
This study is testing a targeted cancer drug called pazopanib for advanced kidney cancer. It specifically welcomes people who feel tired or weak from their illness and need to rest during the day. Researchers want to see how safe the drug is and how well it controls cancer growth.
For: Topic: National Cancer Research Network; Subtopic: Renal Cancer; Disease: KidneyUnited Kingdom · England - CompletedPhase II
A study of pazopanib in metastatic merkel cell carcinoma
This clinical trial is testing a targeted drug called pazopanib in adults with a rare skin cancer called Merkel cell carcinoma. It is for people whose cancer has spread or cannot be removed with surgery, to see if the medicine can help shrink tumours and slow cancer growth.
For: Topic: National Cancer Research Network; Subtopic: Melanoma; Disease: MelanomaUnited Kingdom · England - Active not recruitingPHASE2
Pazopanib Vs. Pazopanib Plus Gemcitabine
This study looks at new ways to treat two types of womb cancer: leiomyosarcoma and carcinosarcoma. It compares a drug called pazopanib on its own with pazopanib combined with another drug, gemcitabine, to see which works better at controlling the cancer.
For: Leiomyosarcoma or CarcinosarcomaGermany - Active not recruitingPHASE3
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
This study compares a new treatment, INT230-6, to standard care for advanced soft tissue sarcoma, a type of cancer. It's for adults whose cancer has grown despite previous treatments. The main goal is to see if INT230-6 helps people live longer.
For: Sarcoma,Soft TissueUnited States · Canada · France